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ABSRACT 
The prevalence of antibiotic resistant bacteria has made the choices for topical treatments for 
patients who experience burns wounds extremely limited. The Staphylococcus genus is naturally 
occurring in and on the human body but can become harmful once it enters the bloodstream. A 
novel antimicrobial gel has been shown by our laboratory to inhibit both the planktonic growth 
and biofilm formation of Staphylococcus aureus in previous studies. The antimicrobial gel is 
made of seven natural compounds including antioxidants (vitamin C and E). We wanted to 
examine the effects of the antimicrobial gel on numerous other Staphylococcal species because it 
is prevalent on the body and becomes harmful when the immune system is compromised. The 
species tested were Staphylococcus capitis, Staphylococcus epidermidis, and Staphylococcus 
saprophyticus. A planktonic broth challenge test, biofilm attachment test, and biofilm maturation 
test were all performed in order to test this hypothesis. These tests showed a significant 
inhibition of the Staphylococcus species as a result of the effects of the antimicrobial gel. The 
antimicrobial gel inhibited the attachment, maturation, and growth of Staphylococcus colonies in 
a 10% antimicrobial gel solution. The antimicrobial gel shows promise as an option in treating 
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 Staphylococcus is a Gram-positive genus of bacteria, which can become pathogenic to 
humans and other animals (1). Staphylococcus typically grows in clusters, pairs, or short chains 
when the Staphylococci divide into two planes (1). This genus is commonly divided into 
coagulase-positive Staphylococci and coagulase-negative Staphylococci, although this does not 
distinguish its virulence factor, but can be used as a marker for Staphylococcus aureus (S. 
aureus) in most cases (1). Staphylococcus has multifactorial pathogenesis, making it difficult to 
determine the role of each factor (1). Although, strains from isolated diseases have shown 
expression in particular factors (1). The Staphylococcus species is the cause of many infections 
associated with internal medical devices. Staphylococcus adheres to fibrinogen and fibronectin 
host cells, which become prevalent on internal medical devices after implantation (1). S. aureus 
can also bind to endothelial tissue, but the mechanism of adherence remains unclear. α-toxin, β-
toxin, δ-toxin, γ-toxin and leucocidin are all membrane damaging toxins (1). Treatments for 
Staphylococcal infections include the surgical removal of the medical device and antibiotics if 
the strain is not resistant (1). Numerous strains of Staphylococcus were shown to develop 
resistance to methicillin and penicillin in the mid 20th century, making vancomycin the primary 
form of treatment for methicillin resistant S. aureus until Vancomycin resistant strains appeared 
in the 1980’s (2). These antibiotic resistant strains have continued to become more prevalent in 
hospitals and there appears to be no new antibiotics to combat the quickly adapting species. 
Staphylococcus epidermidis 
 Staphylococcus epidermidis (S. epidermis), while previously viewed as an innocuous 
microorganism residing on the skin, now presents as an opportunistic pathogen due to the rise in 
nosocomial infections it causes making it comparable to S. aureus (3, 4). Along with nosocomial 
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infections S. epidermidis is recognized as the most common source of infection on internal 
medical devices due to the nature of insertion of these devices during surgery (4,5). The devices 
come into contact with the skin and carry S. epidermidis with them once implanted. S. 
epidermidis does not appear to be life threatening, but is important due to the frequency and 
difficulty treating as a result of antibiotic resistance and biofilm formation (4). 
 S. epidermidis is the most commonly isolated microorganism from the human skin and 
has the ability to acclimate to extreme salt concentrations as well as to varying osmotic pressures 
of the environment (4). It is a very diverse coagulase-negative Staphylococcus species with 74 
identified, unique deoxyribose nucleic acid (DNA) sequences (6,4). It causes the highest number 
of infections among coagulase-negative Staphylococci (CoNS) bacteria and accounts for 22% of 
bloodstream infections in intensive care unit patients in the USA (3,4). It has been shown that S. 
epidermidis was involved in prosthetic joint, vascular graft, surgical site, central nervous system 
shunt, and cardiac device infections as well as accounting for 13% of prosthetic valve 
endocarditis infections, according to Chu, cited by Otto. (4,7) 
Staphylococcus capitis 
 Staphylococcus capitis (S. capitis), just like S. epidermidis, is an opportunistic human 
pathogen and a coagulase-negative Staphylococci bacterium (8). The findings by Van Der Zwet 
and Rasigade cited by Cameron indicate that S. capitis causes up to 20% of neonatal sepsis cases 
in the neonatal ICU (9, 10, 11). It has also contributed to the development of prosthetic valve 
endocarditis and hospital-acquired meningitis in patients (12,9). It is interesting to note that 
CoNS bacteria rely on biofilm formation for their virulence (9, 13). Biofilm production has been 
associated with virulence in the absence of prosthetic material in an animal model (13). This 
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study also found that gene regulation was involved in bacterial virulence, rather than the ica 
operon, as previously suspected (13).  
Staphylococcus saprophyticus 
 Staphylococcus saprophyticus (S. Saprophyticus) is a CoNS bacterium that is a common 
cause of uncomplicated urinary tract infections, making up 42% of all infections, especially 
effecting women ages 16-25 who are sexually active (14). Although more uncommon it is also 
responsible for acute pyelonephritis, urethritis, epididymitis, and prostatitis (14). Unlike other 
CoNS bacteria, it is known to be resistant to the antibiotic, Novobiocin, an aminocoumarin. (14).  
Another study showed that a third of S. saprophyticus urinary tract infection cases were resistant 
to oxacillin, a beta lactam antibiotic. (15) Some strains have the ability to create biofilms to 
increase their virulence and resistance (14).  This bacterium colonizes in the perineum, rectum, 
urethra, cervix, and gastrointestinal tract (14). There is an increased incidence of S. 
saprophyticus infection in patients with nosocomial urinary tract infections, pregnant patients, 
and patients who are urinary catheterized (14). Patients who are more susceptible to S. 
saprophyticus include those who are immunocompromised, HIV positive, diabetic, or elderly 
(14). 
Staphylococcus and topical burn wounds 
The environment of the skin is ideal for bacteria because of the protein rich environment 
found in avascular necrotic tissue (16). Also, the avascular nature of the skin inhibits immune 
cells from entering via the bloodstream. Additionally, the bacterial release of toxins inhibits the 
local immune response. Taken together, the skin provides an enriching area for bacterial growth 
(16). While a burn is sterile immediately afterwards, Gram-positive bacteria, including 
Staphylococcus, residing in sweat glands and hair follicles survive the burn and quickly multiply 
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(16). Gram-positive bacteria colonize the burn area heavily within the first 48 hours without the 
application of an antimicrobial agent (16). Biofilms develop within 48-72 hours (16). Within 5 to 
7 days the burned area becomes colonized with other Gram-positive and Gram-negative bacteria 
and fungi (16). S. aureus is the most common cause of early burn wound infection and has 
continued to become challenging to treat due to antibiotic resistance. 
Current burn wound treatments 
Topical gels decrease morbidity and mortality in patients with burns; however, treatments 
have become limited due to antibiotic resistance (16). Silver nitrate is a less commonly used drug 
that is effective against Gram-negative bacteria (16). It is scarcely used treatment due to the 
potential toxicity, electrolyte imbalances, and discoloration of the wound that may follow 
treatment (16). The most common treatment for burns is silver sulfadiazine, a combination of 
silver nitrate and sulfadiazine (16). It is a broad spectrum antibiotic that is especially toxic to 
Gram-negative bacteria (16). It has been shown to have limited toxicity with once or twice daily 
repeated application, with the addition of leukopenia, low white blood cell count. (16). There are 
a few reported cases of antimicrobial resistance in silver sulfadiazine and it is less effective in 
patients with severe burns because it can only be absorbed within one surface of the epidermal 
layer (16). Another burn treatment is Mafenide acetate, a topical broad spectrum cream that is 
effective against Gram-negative bacteria but has very little effect on Gram-positive bacteria, 
such as the Staphylococcus species (16). This treatment is used sparingly due to its toxicity 
profile (16). Acticoat A.B. dressing has been shown to be effective against aerobic Gram-
positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA), and reduces the 
amount of dressing changes needed after injury (16). It is considered the broadest spectrum 
bacterial coverage against burn wound pathogens currently (16). Mupirocin, a topical antibiotic, 
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has been shown to kill MRSA but should be rotated during treatment to prevent resistance (16). 
Nystatin is an antifungal, topical medication that is used in conjunction with antibiotics, due to 
its lack of toxicity on bacteria (16). Other non-topical treatments include selective bowel 
decontamination, which has been shown to reduce burn wound colonization, and immunization 
of tetanus toxin via intramuscular injection (16). 
Antimicrobial Gel 
 
 Existing antibiotic resistance and the evolving risk for further resistance illuminates the 
importance of new treatments to combat newly evolving pathogens of burn wounds. An 
antimicrobial gel (AMG) made of seven natural components including antioxidants (vitamin C 
and E) and zinc has previously been shown in our lab to inhibit microorganisms that commonly 
infect burn wounds. Previous tests have shown that this AMG has the most significant 
antimicrobial effects against S. aureus biofilms and planktonic cultures (17). The AMG, from 
other lab tests, demonstrate that the effects on pain relief and wound healing are significant (17). 
Taken together, the information suggests it would be useful and versatile in the healthcare field. 
Therefore, it is important to examine the properties of the AMG on other members of the 
Staphylococcus genus (S. capitis, S. epidermidis, S. saprophyticus). It would be useful in wound 
care treatments to determine if this predilection for inhibition of S. aureus could be applied to 
other Staphylococcal species or if it is specific to only S. aureus. 
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MATERIALS AND METHODS 
Strains and Growth Conditions 
Mannitol salt agar (MSA) stock streak plates for isolated colonies were made for S. 
aureus using stock ATCC#25933, S. epidermidis (ATCC #), S. saprophyticus (ATCC #), and S. 
capitis was (ATCC # ) . These plates were incubated at 37°C for twenty-four hours, then sealed 
with parafilm and placed in a 4°C cooler for storage. This process was repeated every two weeks 
to obtain fresh colonies for the following experiments. For all experiments, bacteria were 
propagated in Luria-Bertani (LB) broth and MSA plates. When needed, the AMG was 
supplemented in LB broth in a weight to volume (w/v) to produce a 10% solution.  
Planktonic Broth Challenge Test 
Fresh overnight cultures were inoculated for each Staphylococcal species and grown at 
37°C for twenty-four hours. An optical density (OD 600) was then obtained. Experimental and 
control LB tubes were inoculated using the OD600 reading and adjusting mathematically to 
obtain a final concentration of cells of ~1x106 cells/ml. The bacterial mixture was added to either 
a 5 ml LB tube (control) or a 5 ml 10% AMG LB broth. The tubes were placed in a 37°C 
incubator with shaking (250rpm) for twenty-four hours. Serial dilutions were then performed on 
each sample, plated onto MSA or LB agar plates, and incubated at 37°C for twenty-four hours. 




The attachment assay was conducted to observe the effects of AMG on the 
Staphylococcus attachment phase for biofilm formation. A 10% solution of AMG LB broth was 
added to a 96-well plate with either S. epidermidis, S saprophyticus, S. capitis, and S. aureus 
inoculated at an OD600 of 0.01 which is equivalent to 1x106 cells/ml.  As a control, S. 
epidermidis, S saprophyticus, S. capitis, and S. aureus were also inoculated into LB broth 
without AMG and added to separate wells. The plate was then covered in parafilm and placed at 
37°C for twenty-four hours. The plate was removed, the remaining liquid was drawn off, washed 
with Phosphate Buffered Saline (PBS) and OD600 of the biofilms were measured. A Crystal 
Violet assay was then performed by adding 200 ml of 0.001% CV to the wells, incubating for 
five minutes, drawing the liquid off and rinsing with PBS, then adding 200 ml 33% Glacial 
Acetic Acid for five minutes. This assay was read at OD595 with shaking. This series was 
repeated three times to determine validity. 
Maturation Assay 
A maturation assay was performed by adding S. saprophyticus, S. epidermidis, S. aureus, 
and S. capitis LB broth to a 96-well plate to test the effects of AMG on the maturation phase of 
biofilm growth. Each species was inoculated in LB and grown for twenty-four hours at 37⁰C 
without the addition of AMG. The liquid was then drawn off and 200µl of 10% AMG was added 
to half of the wells, while 200µl of LB was added to the other half of each species biofilm for 
comparison. The well plate was then incubated at 37°C for twenty four hours. The plate was then 
removed and assayed in the same manner as the attachment assay. This series was repeated three 





Planktonic cultures of Staphylococcus species with 10% AMG. 
It has been previously demonstrated in our lab that among a panel of burn wound 
infection microorganisms, that AMG has an increased ability to inhibit S. aureus. We therefore 
set out to determine if this inhibition could be seen in other Staphylococcal species using 
planktonic cultures. Upon inoculating each strain in LB broth, either with or without 10% AMG, 
we found that AMG significantly reduces the growth of S. epidermidis, S. capitis, and S. 
saprophyticus as demonstrated by colony forming units (CFU). Figure 1 shows the significant 
reduction in CFUs when all three Staphylococcal species are grown with 10% AMG over a 
twenty-four-hour period. S epidermidis showed an 81% reduction in CFUs, S. saprophyticus 
showed a 100% reduction in CFUs, and S. capitis showed a 94% reduction in CFUs when 
compared to their LB broth only (no AMG) matched controls. This data is comparatively similar 
to the prior data we obtained when S. aureus is inoculated into LB AMG with a robust inhibition 
of CFUs over a 24-hour period. Taken together, it would appear that the AMG inhibits all 
members of the Staphylococcal family, at least in planktonic culture, equally and not specific for 
only S. aureus inhibition. Figure 2 and 3 are representative photos of one trial of S. 
saprophyticus planktonic cultures with AMG (Figure 3) or without AMG (Figure 2). As shown 
in all three trials, addition of AMG to the culture produced no viable colonies of S. 
saprophyticus. Trials with S. capitis and S. epidermidis produced a similar trend with minimal 
bacterial growth on all dilution plates of the cultures containing 10% AMG (photos not shown).  
 13 
  
Figure 1: Graphical representation of 24 hour planktonic cultures of Staphylococcal species with 
































Figure 2: S. saprophyticus (without AMG) serially diluted to plate 6 which produced 148 
bacterial colonies (one out of three trials) 
 
 
Figure 3: S. saprophyticus (with 10% AMG) serially diluted to plate 1 which produced no 
bacterial colonies (one out of three trials) 
  
Biofilm, attachment phase, of Staphylococcus species with 10% AMG. 
After demonstrating that AMG inhibits not only S. aureus, but also planktonic cultures of S. 
capitis, S. epidermidis, and S. saprophyticus, we turned our attention to biofilm formation. 
Biofilms form in discreet ordered steps beginning with the attachment of planktonic cells to a 
surface. It was postulated that AMG could inhibit the early stage of bacterial biofilm formation. 
AMG showed a significant reduction in biofilm attachment among all Staphylococcal species 
tested. Two different methods were used to quantify biofilm attachment. The first method used 
optical density as a measure to determine the amount of bacterial density present (Figure 4).  S. 
capitis density decreased by 63%, S. epidermidis density decreased by 47%, and S. 
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saprophyticus density decreased by 57% with the application of AMG as compared to controls 
with only LB broth and bacteria. While all three bacterial species were reduced in their ability to 
attach to the 96-well plates, they did so in different amounts of reduction as compared to the 
planktonic growth. In planktonic growth, S. saprophyticus was completely inhibited followed by 
S. capitis, and then S. epidermidis. In the attachment phase, S. saprophyticus had the most 
growth, followed by S. epidermidis and S. capitis. These differences could be due to the growth 
characteristics of planktonic verses biofilm growth. In planktonic growth, the cells are 
continuously bathed in the AMG, whereas in biofilm growth, the bacteria grow in communities 
and the layers of bacteria can protect the community and keep the AMG from penetrating the 
biofilm. 
 
Figure 4: Graphical representation of biofilm growth over a 24 hour period of Staphylococcal 
species with AMG added at the same time as bacteria – Attachment Phase OD600 test (three 




























The second method used CV staining and OD595 readings to determine the amount of 
biofilm density present (Figure 5). S. capitis density decreased by 19%, S. epidermidis density 
decreased by 39%, and S. saprophyticus density decreased by 55% with the application of AMG 
as compared to controls with only LB broth and bacteria. This data correlated with the optical 
density data from Figure 4 with all three species being reduced in their biofilm attachment 
abilities when AMG is added. Again, this inhibition is not as pronounced as the planktonic 
inhibition due to the different growth characteristics between the two forms. This inhibition does 
support the findings of the optical density data as they are proportional to the decreases seen 
from the OD600 readings. 
 
Figure 5: Graphical representation of 24-hour biofilm growth of Staphylococcal species with 

























Biofilm, maturation phase, of Staphylococcus species with 10% AMG. 
After demonstrating that AMG inhibits the attachment phase of biofilms formed by S. 
capitis, S. epidermidis, and S. saprophyticus, the second phase of biofilm growth, mature 
biofilms, was evaluated. In many health care infections, biofilms are already formed on 
implanted devices or wounds. Treatments must then be directed at destroying these pre-formed 
biofilms that can typically be 10 to 1000X more resistant to antibiotics. We therefore wanted to 
determine if AMG could inhibit a later stage of bacterial biofilm formation i.e. an established 
biofilm on a surface. For this biofilm evaluation, bacteria were allowed to grow without AMG 
for 24 hours to create an established bacterial biofilm on the plate surface. After 24 hours, the 
media was removed, 10% AMG-LB was added and the biofilms were incubated for another 24 
hours. The two methods for biofilm quantification were used as previously described.  OD600 
readings indicated that S. capitis density decreased by 39.9%, S. epidermidis density decreased 
by 47.9%, and S. saprophyticus density decreased by 38.1% with the application of AMG as 
compared to controls with only LB broth and bacteria (Figure 6). All three bacterial species 
demonstrated reductions in the mature biofilm coverage in the 96-well plates Again, varying 
amounts of reduction for each species was found when compared to the planktonic growth and 
the biofilm attachment assay. In planktonic growth, S. saprophyticus was completely inhibited 
followed by S. capitis, and then S. epidermidis and in the biofilm attachment phase, S. 
saprophyticus had the most inhibition, followed by S. capitis, and S. epidermidis. In the mature 
biofilm eradication, S. epidermidis had the largest reduction compared to controls, followed by S. 
capitis, and then S. saprophyticus. Since the mature biofilm has different characteristics than 
planktonic and even the biofilm attachment phases, it could be that S. epidermidis is more 
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sensitive at this time point verses the attachment phase to the inhibitory effects of AMG than the 
other Staphylococcal species. 
 
 
Figure 6: Graphical representation of 24-hour biofilm growth of Staphylococcal species with 
AMG only added after bacteria have an initial 24 hour growth – Maturation Phase – OD600 test 
(three separate trials).  
 
The second assessment method again used CV staining and OD595 readings to determine the 
amount of biofilm density present (Figure 7). At this point we found unexpected results. In the 
trials using staining for mature biofilm eradication, there was a large increase in experimental 
verses the control wells for all three Staphylococcal species. These results may be due to errors 
made during the staining and washing process as this data is in complete odds against all of the 
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data. We are currently exploring and re-examining the staining process and will run additional 
experiments to determine the cause of these unexpected results. 
 
Figure 7: Graphical representation of 24-hour biofilm growth of Staphylococcal species with 
AMG only added after bacteria have an initial 24 hour growth – Maturation Phase – CV test 
(three separate trials). 
 
DISCUSSION AND CONCLUSION 
 
Antibiotic resistance is an ever-expanding problem in healthcare and new novel 
medications are needed in treatment rotation to prevent further resistance. The Staphylococcus 
genus is the most common cause of early burn would infections and nontoxic treatments are 
needed to further promote healing of burns without complications. At this time, the majority of 
treatment for burn wound infections have deficiencies such as toxicity, resistance, targeted 
specificity, and stability that do not promote positive outcomes for the patient. The AMG 
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Control 10% AMG
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treatment of S. aureus infections. The results of this thesis, show that AMG reduced colony 
forming units and biofilm attachment, suggesting that this could be used as initial treatment after 
a burn wound has occurred. This data shows that the inhibitory effects of AMG are universally 
present in all species of Staphylococcus testing. If applied directly after a burn, it could prevent 
the attachment of Staphylococcus bacteria and inhibit the establishment of biofilms, resulting in 
the prevention of biofilm maturation that are typically highly drug resistant. AMG was less 
effective in maturation, suggesting that the biofilm matrix is more complex once completely 
developed and may prevent the AMG from reaching all cells. AMG significantly reduced the 
colony forming units, completely depleting S saprophyticus colonies. This suggests that it has a 
greater effect on individual planktonic bacteria than biofilms.  
These results support that AMG reduced Staphylococcus biofilm attachment, maturation, 
and planktonic forms of growth. Future plans include evaluating Gram-positive bacteria and 
other cocci bacteria to evaluate the broad spectrum coverage of AMG. Additionally, varying 
concentrations of AMG will be used to determine if an increase in AMG would be better at 
inhibiting the hardy mature biofilms. Lastly, we plan to delineate the mechanism of action AMG 
has on bacteria, specifically Staphylococcus. AMG should be studied further to examine its 
benefits in application to not only burn treatments, but also as a means to be used 
prophylactically on medical devices and in conjunction with other treatments to prevent 





1) Foster T. Staphylococcus. In: Baron S, editor. Medical Microbiology. 4th edition. 
Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 12. 
Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK8448/  
 
2) McGuinness W., Malachowa N., Deleo F. (2017). Vancomycin Resistance in 
Staphylococcus Aureus. Yale Journal of Biology and Medicine, 90(2): 269–281. 
Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482303/ 
 
3) National Nosocomial Infections Surveillance (NNIS) System Report, data summary 
from January 1992 through June 2004, issued October 2004. National Nosocomial 




4) Otto M. (2009). Staphylococcus epidermidis--the 'accidental' pathogen. Nature reviews.  
 Microbiology, Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807625/ 
 
5) Ilker Uçkay, Didier Pittet, Pierre Vaudaux, Hugo Sax, Daniel Lew & Francis 
Waldvogel (2009) Foreign body infections due to Staphylococcus epidermidis, Annals 
of Medicine, 41:2, 109-119, DOI: 10.1080/07853890802337045 
 
 22 
6) Miragaia M., Thomas J., Couto I., Enright M., Lencastre H. (2007). Inferring a 
Population Structure for Staphylococcus epidermidis from Multilocus Sequence Typing 
Data.  
 
7) Chu VH, Miro JM, Hoen B, et al. (ND). Coagulase-negative staphylococcal prosthetic 
valve endocarditis contemporary update based on the International Collaboration on 
Endocarditis: prospective cohort study Heart 2009;95:570-576. 
 
8) Cui, B., Smooker, P. M., Rouch, D. A., Daley, A. J., & Deighton, M. A. (2013). 
Differences between two clinical Staphylococcus capitis subspecies as revealed by 
biofilm, antibiotic resistance, and pulsed-field gel electrophoresis profiling. Journal of 
Clinical Microbiology, Retrieved from 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536240/ 
 
9) Cameron, D. R., Jiang, J. H., Hassan, K. A., Elbourne, L. D., Tuck, K. L., Paulsen, I. 
T., & Peleg, A. Y. (2015). Insights on virulence from the complete genome of 
Staphylococcus capitis. Frontiers in microbiology, 6, 980. Retrieved from 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585213/ 
 
10) Van Der Zwet, W. C., Debets-Ossenkopp, Y. J., Reinders, E., Kapi, M., Savelkoul, P. 
H., Van Elburg, R. M., Hiramatsu, K., & Vandenbroucke-Grauls, C. M. (2002). 
Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to 
 23 
vancomycin in a neonatal intensive care unit. Journal of clinical microbiology, 40(7), 
2520–2525. https://doi.org/10.1128/jcm.40.7.2520-2525.2002 
 
11) Rasigade, J. P., Raulin, O., Picaud, J. C., Tellini, C., Bes, M., Grando, J., Ben Saïd, M., 
Claris, O., Etienne, J., Tigaud, S., & Laurent, F. (2012). Methicillin-resistant 
Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis 
in intensive care neonates. PloS one, 7(2), e31548. 
https://doi.org/10.1371/journal.pone.0031548 
 
12) Bandres J., Darouiche R. (1992). Staphylococcus capitis Endocarditis: A New Cause of 
an Old Disease. Clinical Infectious Diseases, 14(1), 366-367. Retrieved from 
www.jstor.org/stable/4456291 
 
13) de Silva, G. D., Kantzanou, M., Justice, A., Massey, R. C., Wilkinson, A. R., Day, N. 
P., & Peacock, S. J. (2002). The ica operon and biofilm production in coagulase-
negative Staphylococci associated with carriage and disease in a neonatal intensive care 
unit. Journal of clinical microbiology, 40(2), 382–388. 
https://doi.org/10.1128/jcm.40.02.382-388.2002 
 
14) Ehlers S, Merrill SA. Staphylococcus Saprophyticus. [Updated 2019 Mar 27]. In: 




15) Orden-Martínez., Martínez-Ruiz, R., & Millán-Pérez, R. (2008). What are we learning 
from Staphylococcus saprophyticus? Infectious Diseases and Clinical Microbiology, 
26(8), 495–499. Retrieved from https://doi.org/10.1016/S0213-005X(08)72777-0 
 
16) Elsayed, S., Reid, O., Lindsay, R., Deirdre Church, & Brent Winston. (2006, April 1). 
Burn Wound Infections. American Society for Microbiology, N/P. Retrieved from  
 https://cmr.asm.org/content/19/2/403#sec-21 
 
17) Vance L. (2018). The Inhibitory Effects of a Novel Gel on Staphylococcus aureus 
Biofilms. East Tennessee State University. 2-28. Retrieved from 
https://dc.etsu.edu/cgi/viewcontent.cgi?article=1476&context=honors  
  
 25 
 
 
 
 
